BALLESTRI, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.585
AS - Asia 2.616
EU - Europa 2.457
SA - Sud America 365
Continente sconosciuto - Info sul continente non disponibili 92
AF - Africa 51
OC - Oceania 13
Totale 13.179
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.423
SG - Singapore 839
CN - Cina 650
GB - Regno Unito 612
IT - Italia 346
VN - Vietnam 312
FI - Finlandia 285
HK - Hong Kong 285
BR - Brasile 265
PL - Polonia 243
SE - Svezia 233
DE - Germania 217
BD - Bangladesh 132
RU - Federazione Russa 113
FR - Francia 105
UA - Ucraina 99
TR - Turchia 84
CA - Canada 72
IN - India 60
BG - Bulgaria 48
JP - Giappone 41
ID - Indonesia 39
AR - Argentina 35
KR - Corea 32
LT - Lituania 28
NL - Olanda 27
MX - Messico 22
PK - Pakistan 18
MY - Malesia 17
VE - Venezuela 16
ZA - Sudafrica 16
IQ - Iraq 15
CR - Costa Rica 14
ES - Italia 14
EC - Ecuador 13
IE - Irlanda 12
PH - Filippine 12
SV - El Salvador 11
BE - Belgio 10
CZ - Repubblica Ceca 10
GR - Grecia 10
HN - Honduras 10
JM - Giamaica 10
UZ - Uzbekistan 10
CO - Colombia 9
SA - Arabia Saudita 9
GT - Guatemala 8
AU - Australia 7
BO - Bolivia 7
CL - Cile 7
CW - ???statistics.table.value.countryCode.CW??? 7
NP - Nepal 7
PE - Perù 7
AT - Austria 6
EG - Egitto 6
NZ - Nuova Zelanda 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
KE - Kenya 5
OM - Oman 5
SI - Slovenia 5
TH - Thailandia 5
AL - Albania 4
DZ - Algeria 4
EU - Europa 4
IL - Israele 4
MA - Marocco 4
TW - Taiwan 4
CH - Svizzera 3
JO - Giordania 3
LB - Libano 3
NI - Nicaragua 3
RS - Serbia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AM - Armenia 2
AZ - Azerbaigian 2
BB - Barbados 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
GP - Guadalupe 2
HU - Ungheria 2
IR - Iran 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
NO - Norvegia 2
PT - Portogallo 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
AO - Angola 1
BH - Bahrain 1
Totale 13.076
Salva come PNG Salva come JPEG
Città #
Ashburn 855
Fairfield 759
Singapore 552
Santa Clara 527
Woodbridge 462
Houston 364
Seattle 340
Southend 338
Chandler 312
San Jose 309
Wilmington 301
Hong Kong 281
Helsinki 255
Cambridge 246
Warsaw 241
Council Bluffs 221
Dearborn 192
Ann Arbor 182
Nyköping 165
Jacksonville 137
Beijing 132
New York 129
London 118
Chicago 114
Los Angeles 111
Hefei 108
Ho Chi Minh City 87
Modena 82
Boardman 76
Hanoi 76
The Dalles 61
Columbus 49
Sofia 46
Princeton 45
Eugene 43
Izmir 43
Salt Lake City 43
San Diego 43
Milan 38
Lauterbourg 36
Moscow 35
Dallas 34
Shanghai 31
São Paulo 31
Seoul 30
Buffalo 29
Frankfurt am Main 25
Tokyo 25
Jakarta 24
Munich 23
Phoenix 22
Tampa 21
Manchester 20
Elk Grove Village 18
Denver 17
Orem 17
Redwood City 17
Atlanta 16
Chennai 15
Des Moines 15
North Bergen 15
Da Nang 14
Rome 14
San Mateo 13
Amsterdam 12
Athens 12
Haiphong 12
Naples 12
Toronto 12
Dublin 11
Guangzhou 11
San Salvador 11
Dong Ket 10
Florence 10
Kansas City 10
Saint Augustine 10
San José 10
Bologna 9
Bremen 9
Brooklyn 9
Jersey City 9
Kunming 9
Lancaster 9
Montreal 9
North Salt Lake 9
Paris 9
Redondo Beach 9
San Francisco 9
Tashkent 9
Biên Hòa 8
Brno 8
Brussels 8
Johannesburg 8
Kuala Lumpur 8
Las Vegas 8
Mexico City 8
Miami 8
Miano 8
Nanjing 8
Padova 8
Totale 9.379
Salva come PNG Salva come JPEG
Nome #
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 550
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 508
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 464
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis 409
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 408
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 401
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis 400
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk 398
Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma 388
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 388
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 387
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV 355
Clinical relevance of liver histopathology and different histological classifications of NASH in adults 347
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 346
Nonalcoholic fatty liver disease and aging: epidemiology to management 346
A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue? 331
A critical appraisal of the use of ultrasound in hepatic steatosis 326
Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis. 324
Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease? 316
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 302
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 301
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. 299
Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases 297
Treatment of atherogenic liver based on the pathogenesis of nonalcoholic Fatty liver disease: a novel approach to reduce cardiovascular risk? 295
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 293
Alcohol and Steatosis: The Japanese Paradox 286
Non-alcoholic Fatty Liver Disease: a HR-MAS analysis 271
Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity? 270
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? 262
Gli enzimi epatobiliari nella diagnostica clinica delle Epatopatie. 261
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications 249
Type 2 diabetes in non-alcoholic fatty liver disease and hepatitis c virus infection—liver: The “Musketeer” in the spotlight 249
Inflammatory hepatocellular adenomatosis, metabolic syndrome, polycystic ovary syndrome and non-alcoholic steatohepatitis: Chance tetrad or association by necessity? 222
The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology 219
The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment 217
Nanoparticles: potential toxins for the organism and the kidney ? 214
Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent? 213
Sex Differences in NAFLD: State of the Art and Identification of Research Gaps 213
The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans 210
Hypervascular Retroperitoneal Mass in a Patient with Fever and Leucocytosis - Contrast-Enhanced Ultrasonographic Findings in a Case of Inflammatory Malignant Fibrous Histiocytoma 206
NAFLD, Hepatotropic Viruses, and Cardiometabolic Risk 176
Liver fibrosis biomarkers accurately exclude advanced fibrosis and are associated with higher cardiovascular risk scores in patients with NAFLD or viral chronic liver disease 144
Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease 118
Totale 13.179
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.327
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022545 0 0 0 0 17 37 48 29 102 75 172 65
2022/2023827 82 126 62 76 87 116 16 79 96 8 34 45
2023/2024457 15 25 42 24 97 61 21 39 10 4 56 63
2024/20251.754 48 21 36 121 361 252 143 135 178 71 167 221
2025/20264.164 221 108 241 411 652 562 602 177 430 302 222 236
2026/20271.103 109 260 198 500 36 0 0 0 0 0 0 0
Totale 13.179